Role of Shc in T-cell development and function

Immunological Reviews

Volumn 191, Issue , 2003, Pages 183-195

  Zhang, Li ^a   Lorenz, Ulrike ^a   Ravichandran, Kodi S ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; T LYMPHOCYTE RECEPTOR;

CELL MATURATION; ENZYME ACTIVATION; HUMAN; KNOCKOUT MOUSE; LEUKEMIA CELL LINE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; HUMANS; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0037306480     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2003.00025.x     Document Type: Review

References (89)

1. van Oers NS. T cell receptor-mediated signs and signals governing T cell development. Semin Immunol 1999;11:227-237.
2. van Leeuwen JE, Samelson LE. T cell antigen-receptor signal transduction. Curr Opin Immunol 1999;11:242-248.
3. Wange RL, Samelson LE. Complex complexes: signaling at the TCR. Immunity 1996;5:197-205.
4. Dustin ML. Membrane domains and the immunological synapse, keeping T cells resting and ready. J Clin Invest 2002;109:155-160.
5. Dustin ML. Role of adhesion molecules in activation signaling in T lymphocytes. J Clin Immunol 2001;21:258-263.
6. Sedwick CE, Altman A. Ordered just so: lipid rafts and lymphocyte function. Sci STKE 2002; RE2 (2002).
7. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994,;76:263-274.
8. Miller AT, Berg LJ. New insights into the regulation and functions of Tec family tyrosine kinases in the immune system. Curr Opin Immunol 2002;14:331-340.
9. Lewis CM, Broussard C, Czar MJ, Schwartzberg PL. Tec kinases: modulators of lymphocyte signaling and development. Curr Opin Immunol 2001;13:317-325.
10. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 1992;71: 649-662.
11. van Oers NS, Weiss A. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes. Semin Immunol 1995;7:227-236.
12. Samelson LE. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu Rev Immunol 2002;20:371-394.
13. Yablonski D, Weiss A. Mechanisms of signaling by the hematopoietic-specific adaptorproteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv Immunol 2001;79:93-128.
14. Tomlinson MG, Lin J, Weiss A. Lymphocytes with a complex: adapter proteins in antigen receptor signaling. Immunol Today 2000;21:584-591.
15. Clements JL, Boerth NJ, Lee JR, Koretzky GA. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol 1999;17:89-108.
16. Liu SK, McGlade CJ. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc. Oncogene 1998;17:3073-3082.
17. Liu SK, Fang N, Koretzky GA, McGlade CJ. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr Biol 1999;9:67-75.
18. Pelicci G, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992;70:93-104.
19. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001;20:6322-6330.
20. Luzi L, Confalonieri S, Di lkFiore PP, Pelicci PG. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 2000;10:668-674.
21. Baldari CT, Telford JL. Lymphocyte antigen receptor signal integration and regulation by the SHC adaptor. Biol Chem 1999;380:129-134.
22. Zhou MM, et al. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 1995;378:584-592.
23. Zhou MM, et al. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc Natl Acad Sci USA 1995;92:7784-7788.
24. Margolis B, Borg JP, Straight S, Meyer D. The function of PTB domain proteins. Kidney Int 1999;56:1230-1237.
25. Pawson T, Gish GD, Nash P. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 2001;11:504-511.
26. Lai KM, Olivier Jp, Gish GD, Henkemeyer M, McGlade J, Pawson T. A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase. Mol Cell Biol 1995;15:4810-4818.
27. Lai KM, Pawson T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev 2000;14:1132-1145.
28. Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, Burakoff SJ. Interaction of Shc with the ζ chain of the T cell receptor upon T cell activation. Science 1993;262:902-905.
29. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci USA 1996;93:5275-5280.
30. Sieh M, Batzer A, Schlessinger J, Weiss A. GRB2 and phospholipase C-γ 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol Cell Biol 1994;14:4435-4442.
31. Iwashima M, et al. Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc Natl Acad Sci USA 2002;99:4544-4549.
32. Walk SF, March ME, Ravichandran KS. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc. Eur J Immunol 1998;28:2265-2275.
33. Harmer SL, DeFranco AL. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol Cell Biol 1997;17:4087-4095.
34. van der Geer P, Wiley S, Gish GD, Pawson T. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/260) that mediate protein-protein interactions. Curr Biol 1996;6:1435-1444.
35. Gotoh N, Tojo A, Shibuya M. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3. EMBO J 1996;15:6197-6204.
36. Gotoh N, Toyoda M, Shibuya M. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol Cell Biol 1997;17:1824-1831.
37. Pratt JC, van den Brink MR, Igras VE, Walk SF, Ravichandran KS, Burakoff SJ. Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J Immunol 1999;163:2586-2591.
38. Pacini S, et al. Tyrosine 474 of ZAP-70 is required for association with the Shc adaptor and for T-cell antigen receptor-dependent gene activation. J Biol Chem 1998;273:20487-20493.
39. Milia E, et al. The aminoterminal phosphotyrosine binding domain of Shc associates with ZAP-70 and mediates TCR dependent gene activation. Oncogene 1996;13:767-775.
40. Burns LA, Karnitz LM, Sutor SL, Abraham RT. Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J Biol Chem 1993;268:17659-17661.
41. Galandrini R, Palmieri G, Paolini R, Piccoll M, Frati L, Santoni A. Selective binding of shc-SH2 domain to tyrosine-phosphorylated ζ- but not γ-chain upon CD16 ligation on human NK cells. J Immunol 1997;159:3767-3773.
42. Osman N, Lucas SC, Turner H, Cantrell D. A comparison of the interaction of Shc and the tyrosine kinase ZAP-70 with the T cell antigen receptor ζ chain tyrosine-based activation motif. J Biol Chem 1995;270:13981-13986.
43. Marengere LE, Waterhouse P, Duncan GS. Mittrucker HW, Feng GS, Mak TW. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996;272:1170-1173.
44. Plyte S, et al. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts. Oncogene 2000;19:1529-1537.
45. Lemmon MA, Ferguson KM. Molecular determinants in pleckstrin homology domains that allow specific recognition of phosphoinositides. Biochem Soc Trans 2001;29:377-384.
46. Ravichandran KS, et al. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol Cell Biol 1997;17:5540-5549.
47. Medema RH, Bos JL. The role of p21ras in receptor tyrosine kinase signaling. Crit Rev Oncog 1993;4:615-661.
48. Garbay C, Liu WQ, Vidal M, Roques BP. Inhibitors of Ras signal transduction as antitumor agents. Biochem Pharmacol 2000;60:1165-1169.
49. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates the Grb2 association with mSOS. Ann NY Acad Sci 1995;766:202-203.
50. Kaye J. Regulation of T cell development in the thymus. Immunol Res 2000;21:71-81.
51. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
52. Roose J, Weiss AT cells: getting a GRP on Ras. Nat Immunol 2000;1:275-276.
53. von Boehmer H, et al. Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol 1999;11:135-142.
54. von Boehmer H, et al. Crucial function of the pre-T-cell receptor (TCR) in TCR β selection, TCR β allelic exclusion and αβ versus γδ lineage commitment. Immunol Rev 1998;165:111-119.
55. Kruisbeek AM, Haks MC, Carleton M, Michie AM, Zuniga-Pflucker JC, Wiest DL. Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol Today 2000;21:637-644.
56. Hedrick SM. T cell development: bottoms-up. Immunity 2002;16:619-622.
57. Berg LJ, Kang J. Molecular determinants of TCR expression and selection. Curr Opin Immunol 2001;13:232-241.
58. Zhang L, Camerini V, Bender TP, Ravichandran KS. A nonredundant role for the adapter protein Shc in thymic T cell development. Nat Immunol 2002;3:749-755.
59. Lakso M, et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 1992;89:6232-6236.
60. Buckland J, Pennington DJ, Bruno L, Owen MJ. Co-ordination of the expression of the protein tyrosine kinase p56 (lck) with the pre-T cell receptor during thymocyte development. Eur J Immunol 2000;30:8-18.
61. Lee PP, et al. A critical role for dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001;15:763-774.
62. Shimizu C, et al. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol 2001;13:105-117.
63. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995;269:1427-1429.
64. Aifantis I, et al. Allelic exclusion of the T cell receptor beta locus requires the SH2 domain-containing leukocyte protein (SLP) -76 adaptor protein. J Exp Med 1999;190:1093-1102.
65. Zhang W, et al. Essential role of LAT in T cell development. Immunity 1999;10:323-332.
66. -/- mice in the absence of TCR β chain expression. Int Immunol 1994;6:995-1001.
67. Nelson BH. Interleukin-2 signaling and the maintenance of self-tolerance. Curr Dir Autoimmun 2002;5:92-112.
68. Ballard DW. Molecular mechanisms in lymphocyte activation and growth. Immunol Res 2001;23:157-166.
69. Minami Y, Taniguchi T. IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr Opin Cell Biol 1995;7:156-162.
70. Taniguchi T, et al. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann NY Acad Sci 1995;766:235-244.
71. Ravichandran KS, Burakoff SJ. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem 1994;269:1599-1602.
72. Friedmann MC, Migone TS, Russell SM, Leonard WJ. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA 1996;93:2077-2082.
73. Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. J Immunol 1998;161:4627-4633.
74. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 1999;11:281-288.
75. Gu H, et al. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol Cell Biol 2000;20:7109-7120.
76. Palmer E. Shc: a dominant player after ten seasons. Nat Immunol 2002;3:710-711.
77. Migliaccio E, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309-313.
78. + fraction of chronic myelogenous leukemias. Cancer Res 2000;60:728-732.
79. Radtke F, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch 1. Immunity 1999;10:547-558.
80. Damen JE, Liu L, Cutler RL, Krystal G. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 1993;82:2296-2303.
81. Lamkin TD, Walk SF, Liu L, Damen JE, Krystal G, Ravichandran KS. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J Biol Chem 1997;272:10396-10401.
82. Liu Q, et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 1998;188:1333-1342.
83. Helgason CD, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 1998;12:1610-1620.
84. Schmandt R, Liu SK, McGlade CJ. Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells. Oncogene 1999;18:1867-1879.
85. Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998;8:723-732.
86. Sedwick CE, Altman A. Ordered just so: lipid rafts and lymphocyte function. Sci STKE 2002;2002:RE2.
87. Brown D. Structure and function of membrane rafts. Int J Med Microbiol 2002;291:433-437.
88. Saint-Ruf C, Panigada M, Azogui O, Debey P, von Boehmer H, Grassi F. Different initiation of pre-TCR and γδ TCR signalling. Nature 2000;406:524-527.
89. Clements JL, et al. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 1998;281:416-419.